Quest Diagnostics Lifts HY Outlook

Quest Diagnostics Inc. (DGX) said that it raised its earnings per share outlook for the first half of 2021 to range of $7.51 - $8.01 from the prior estimation of $5.07 - $6.07 per share.

The company now expects adjusted earnings per share for the first half of 2021 to be in the range of $6.30 - $6.80 compared to the prior estimation of $5.90 - $6.90.

The company increased its net revenues outlook for the first half of 2021 to a range of $5.00 billion - $5.20 billion from the previous outlook of $4.85 billion - $5.15 billion.

The company expects to launch an accelerated share repurchase in the amount of approximately $1.5 billion in the coming days.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT